Loading…
Loading…
NGVT does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for NGVT and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for NGVT and 80,000+ other tickers.
See exactly how NGVT's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NGVT and 80,000+ other tickers.
Ingevity Corporation (NGVT) is a global provider specializing in the production and distribution of advanced chemical solutions and activated carbon products. The company's reach extends across North America, the Asia Pacific region, Europe, the Middle East, Africa, and South America. Its business operations are organized into two principal divisions: Performance Materials and Performance Chemicals. The Performance Materials segment focuses on the engineering, manufacturing, and sale of chemically activated carbon products, primarily derived from hardwood. These materials are chiefly utilized…
Mosaic (NYSE: MOS - Get Free Report) and Ingevity (NYSE: NGVT - Get Free Report) are both mid-cap materials companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk. Institutional and Insider Ownership 77.5% of Mosaic shares are
Ingevity's Q2 adjusted EBITDA rose to $115 million, driven by favorable pricing, product mix and volumes, prompting higher 2026 earnings guidance.
Shares of Ingevity Corporation (NYSE: NGVT - Get Free Report) have received a consensus rating of "Hold" from the five analysts that are presently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1-year target price among
NGVT's portfolio reshaping, acquisitions and strong cash flow support growth, while APT weakness and macro risks cloud the outlook.
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced today that it will release its third quarter 2026 earnings after the stock market close on Wednesday, November 4, 2026.